ACXP
Acurx Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.88
-1.13 ▼ -22.55%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$3.97
+0.09 ▲ +2.32%
| Index | - | P/E | - | EPS (ttm) | -5.93 | Insider Own | 8.12% | Shs Outstand | 0.00B | Perf Week | 187.41% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 3.09% | Insider Trans | - | Shs Float | 0.00B | Perf Month | 97.96% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -1.2 | Inst Own | 5.44% | Short Float | 2.47% | Perf Quarter | -9.56% |
| Income | -0.01B | P/S | - | EPS this Y | 59.46% | Inst Trans | 3.93% | Short Ratio | 0.02 | Perf Half Y | -9.13% |
| Sales | 0.00B | P/B | 1.73 | EPS next 5Y | 26.94% | ROA | -137.98% | Short Interest | 0.06M | Perf YTD | 55.82% |
| Book/sh | 2.24 | P/C | 1.47 | EPS past 3/5Y | 38.05% 10.54% | ROE | -270.8% | 52W High | -81.52% ($21.00) | Perf Year | -57.65% |
| Cash/sh | 2.65 | P/FCF | - | Sales past 3/5Y | - | ROIC | -151.21% | 52W Low | 192.63% ($1.33) | Perf 3Y | -94.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 61.1% | Gross Margin | - | Volatility(W/M) | 48.9% 19.39% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.65 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.18 | EPS Q/Q | 79.42% | Profit Margin | - | RSI (14) | 60.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.18 | Sales Q/Q | - | SMA20 | 74.72% ($2.22) | Beta | -1.98 | Target Price | $17 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 61.19% ($2.41) | Rel Volume | 2.22 | Prev Close | $5.01 |
| Employees | 4 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 27.96% - | SMA200 | -23.55% ($5.08) | Avg Volume(3M) | 2.64M | Price | $3.88 |
| IPO | 2021/6/25 | Option/Short | No/No | Trades | 23667 | Volume | 5,863,387 | Change | -22.55% |
뉴스 로딩 중...